IL6 and neoplasm: In an ovarian cancer model, tumor-driven Satb1 overexpression in terminally differentiated DCs results in a tolerant, pro-inflammatory state as evidenced by the secretion of Galectin-1 and IL-6, promoting tumor growth and immune evasion (30).